Better Marijuana Stock to Buy: Cronos or Canopy Growth?
Cronos Group (NASDAQ: CRON) and Canopy Growth (NYSE: CGC) are two highly promising cannabis companies competing in the recreational and medicinal markets worldwide. Surfing a wave of cannabis legalization in the U.S. and elsewhere, Cronos and Canopy are favorites among pure-play marijuana investors and growth investors alike. But these two companies are at slightly different points in their lifecycles -- an important difference when deciding which stock to pick and how long to hold it.
Canopy has a favorable position in several geographical markets. It's attempting to push out new products and expand its production capacity while clamping down on excessive costs during its seemingly endless growth spurt. In contrast, Cronos is fighting to increase its market share while investing in research to secure the future dominance of its leading product segments. Let's take a peek at each company's status to determine which might be a better pick for your portfolio.
Image source: Getty Images.
Source Fool.com
